Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up – Here’s Why

Eurofins Scient (OTCMKTS:ERFSF) shares gapped up before the market opened on Tuesday . The stock had previously closed at $74.47, but opened at $82.1220. Eurofins Scient shares last traded at $79.1660, with a volume of 24 shares trading hands.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on ERFSF shares. Citigroup reaffirmed a “neutral” rating on shares of Eurofins Scient in a research report on Wednesday, October 22nd. BNP Paribas raised Eurofins Scient to an “outperform” rating in a report on Monday. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Eurofins Scient in a research report on Wednesday, October 29th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold”.

Eurofins Scient Stock Down 2.0%

The stock has a 50-day moving average price of $70.69 and a two-hundred day moving average price of $73.06. The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77.

About Eurofins Scient

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.